Halozyme Therapeutics (HALO) has reportedly spent up to $1.3 billion in acquiring three biotech startups in recent months.
The patented Aerio™ platform was designed to meet the highest standards of device function and form from food allergies to modern medical countermeasures ...
Pharmaceutical Technology on MSN
High-dose biologic delivery to become industry standard
As more drugs go subcutaneous, Phillips Medisize's Tony Bedford believes that high-dose biologics will become a prevalent choice for drugmakers.
Polymer micelles are tiny, self-assembled particles that are revolutionizing the landscape of drug delivery and nanomedicine. They form when polymer chains containing both hydrophilic and hydrophobic ...
VANCOUVER, BC / ACCESS Newswire / February 17, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...
If you're ever faced with trying to pick up a grain of rice with a pair of chopsticks, spare a thought for the scientists behind this latest innovation, which has been called "a medical breakthrough ...
Avery Pharmaceuticals Pvt. Ltd., a specialty pharmaceutical company and leading innovator in advanced oral drug delivery ...
MGS has brought a 300,000 square foot drug delivery device manufacturing facility online in Richfield, Wisconsin.
AZoLifeSciences on MSN
Overcoming endosomal escape in oligonucleotide drug delivery
This study addresses endosomal escape in oligonucleotide therapies and how engineered peptides can enhance intracellular drug delivery efficiency.
German Merck has set up a new collaboration with U.K. medtech company Calla Lily Clinical Care to work on its next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results